Kevin Davies

  • Author, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing
  • Guggenheim Fellow 2017
  • Executive Editor, The CRISPR Journal
  • Founding Editor, Nature Genetics


British science writer Kevin Davies, Ph.D., is the author of EDITING HUMANITY: The CRISPR Revolution and the New Era of Genome Editing (Pegasus Books, 2020). Kevin’s latest book is the riveting story of the development of the Nobel Prize-winning technology for editing genes, driving breakthroughs in science, medicine, and agriculture, while igniting ethical controversies about designer babies and the future of humanity. Kevin won a Guggenheim Fellowship for science writing in 2017.

Kevin has 30 years’ experience in science publishing and public speaking. He is the founding editor of Nature Genetics and currently the Executive Editor of The CRISPR Journal. His previous books include Breakthrough: The Race for the Breast Cancer Gene; Cracking the Genome (translated into 15 languages), an inside account of the race for the Human Genome Project hailed by one reviewer as “A rollicking good tale about an enduring intellectual monument”; and The $1000 Genome, which details the revolution in personalized medicine and consumer genetics. He also collaborated with Nobel laureate Jim Watson and Andrew Berry on DNA: The Story of the Genetic Revolution.

Kevin’s presentations blend personal insights, humor, cutting-edge science and a gift for making the impact of 21st-century technology and genetic science fun and accessible to a very broad audience.

 

Add to my speaker list
Kevin  Davies headshot
Kevin  Davies photo 3
Kevin  Davies photo 2
Rave Reviews About Kevin Davies

"Kevin's talk was very well received...there were about 200+ people who stayed specifically for his presentation so it clearly was a large draw." - Jamie Berendt, The American College of Rheumatology



A Sample of the Groups That Have Hosted Kevin Davies
  • NDCHealth
  • British Colombia Pharmacy Association
  • Association of Home Office Underwriters
  • Takeda / Millennium
  • Molecular Medicine Tri-Conference
  • Truven Top 100 Hospitals
  • The American College of Rheumatology
  • International Symposium of Human Identification
  • Novartis Institute of Biomedical Research
  • Informa
Kevin Davies on Conversations That Matter - $1,000 Genome - Get Sharable Link
Explore Kevin Davies's Talks

The CRISPR Revolution and Genome Editing

...

The Science and Ethics of Designer Babies

...

The $1000 Genome

...

A Brief History of The Human Genome Project

...

Personalized Medicine and Consumer Genomics

...

Learn more about Kevin Davies
Follow   Facebook  LinkedIn  Twitter 
Books by Kevin Davies
(+)
Tweets by Kevin Davies
(+)
Biography

British science writer Kevin Davies, Ph.D., is the author of EDITING HUMANITY: The CRISPR Revolution and the New Era of Genome Editing (Pegasus Books, 2020). Kevin’s latest book is the riveting story of the development of the Nobel Prize-winning technology for editing genes, driving breakthroughs in science, medicine, and agriculture, while igniting ethical controversies about designer babies and the future of humanity. Kevin won a Guggenheim Fellowship for science writing in 2017.

Kevin has 30 years’ experience in science publishing and public speaking. He is the founding editor of Nature Genetics and currently the Executive Editor of The CRISPR Journal. His previous books include Breakthrough: The Race for the Breast Cancer Gene; Cracking the Genome (translated into 15 languages), an inside account of the race for the Human Genome Project hailed by one reviewer as “A rollicking good tale about an enduring intellectual monument”; and The $1000 Genome, which details the revolution in personalized medicine and consumer genetics. He also collaborated with Nobel laureate Jim Watson and Andrew Berry on DNA: The Story of the Genetic Revolution.

Kevin’s presentations blend personal insights, humor, cutting-edge science and a gift for making the impact of 21st-century technology and genetic science fun and accessible to a very broad audience.